ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
547 hedge funds and large institutions have $42.4B invested in Alexion Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 206 increasing their positions, 190 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
8% more repeat investments, than reductions
Existing positions increased: 206 | Existing positions reduced: 190
5% less call options, than puts
Call options by funds: $168M | Put options by funds: $177M
Holders
547
Holding in Top 10
21
Calls
$168M
Puts
$177M
Top Buyers
| 1 | +$122M | |
| 2 | +$91.8M | |
| 3 | +$68.3M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$67.5M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$65.4M |
Top Sellers
| 1 | -$133M | |
| 2 | -$108M | |
| 3 | -$89.5M | |
| 4 |
Morgan Stanley
New York
|
-$76M |
| 5 |
HM
HealthCor Management
New York
|
-$74.4M |